KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 192 filers reported holding KITE PHARMA INC in Q4 2016. The put-call ratio across all filers is 2.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $25,631,000 | +46.9% | 142,546 | -15.3% | 0.08% | +36.1% |
| Q2 2017 | $17,442,000 | +318.3% | 168,246 | +216.6% | 0.06% | +221.1% |
| Q1 2017 | $4,170,000 | +1450.2% | 53,136 | +785.6% | 0.02% | +1800.0% |
| Q4 2016 | $269,000 | -96.7% | 6,000 | -95.9% | 0.00% | -97.4% |
| Q3 2016 | $8,115,000 | +680.3% | 145,265 | +598.4% | 0.04% | +680.0% |
| Q2 2016 | $1,040,000 | -14.5% | 20,800 | -21.5% | 0.01% | -28.6% |
| Q1 2016 | $1,216,000 | -7.6% | 26,481 | +24.0% | 0.01% | -12.5% |
| Q4 2015 | $1,316,000 | +148.8% | 21,350 | +124.6% | 0.01% | +166.7% |
| Q3 2015 | $529,000 | -78.3% | 9,507 | -76.2% | 0.00% | -81.2% |
| Q2 2015 | $2,435,000 | +208.2% | 39,950 | +191.5% | 0.02% | +166.7% |
| Q1 2015 | $790,000 | -21.5% | 13,703 | -61.2% | 0.01% | -40.0% |
| Q3 2014 | $1,007,000 | – | 35,346 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |